vs
HERC HOLDINGS INC（HRI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是HERC HOLDINGS INC的1.2倍（$35.5M vs $30.1M），RECURSION PHARMACEUTICALS, INC.净利率更高（-304.2% vs -331.7%，领先27.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 629.3%），HERC HOLDINGS INC自由现金流更多（$-14.3M vs $-47.3M）
Herc Holdings Inc.是北美领先的设备租赁服务供应商，主营工程重型机械、电动工具、临时供电及温控系统租赁业务，服务覆盖建筑、工业、商业活动、基建及政府等领域，业务遍布美国与加拿大。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
HRI vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.2倍
$30.1M
营收增速更快
RXRX
高出52.5%
629.3%
净利率更高
RXRX
高出27.4%
-331.7%
自由现金流更多
HRI
多$33.0M
$-47.3M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $35.5M |
| 净利润 | $-99.9M | $-108.1M |
| 毛利率 | 42.3% | 59.8% |
| 营业利润率 | -77.4% | -304.8% |
| 净利率 | -331.7% | -304.2% |
| 营收同比 | 629.3% | 681.7% |
| 净利润同比 | -866.2% | 39.6% |
| 每股收益（稀释后） | $-0.36 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRIRXRX
| Q4 25 | $30.1M | $35.5M | ||
| Q3 25 | $10.1M | $5.2M | ||
| Q2 25 | $6.3M | $19.2M | ||
| Q1 25 | $4.2M | $14.7M | ||
| Q4 24 | $4.1M | $4.5M | ||
| Q3 24 | — | $26.1M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $13.8M |
净利润HRIRXRX
| Q4 25 | $-99.9M | $-108.1M | ||
| Q3 25 | $-7.5M | $-162.3M | ||
| Q2 25 | $-10.8M | $-171.9M | ||
| Q1 25 | $-14.1M | $-202.5M | ||
| Q4 24 | $-10.3M | $-178.9M | ||
| Q3 24 | — | $-95.8M | ||
| Q2 24 | — | $-97.5M | ||
| Q1 24 | — | $-91.4M |
毛利率HRIRXRX
| Q4 25 | 42.3% | 59.8% | ||
| Q3 25 | 25.8% | -183.8% | ||
| Q2 25 | 53.1% | -4.9% | ||
| Q1 25 | 35.0% | -48.0% | ||
| Q4 24 | 21.4% | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率HRIRXRX
| Q4 25 | -77.4% | -304.8% | ||
| Q3 25 | -153.5% | -3327.6% | ||
| Q2 25 | -147.4% | -916.8% | ||
| Q1 25 | -242.7% | -1297.9% | ||
| Q4 24 | -206.3% | -4042.4% | ||
| Q3 24 | — | -377.1% | ||
| Q2 24 | — | -697.4% | ||
| Q1 24 | — | -698.4% |
净利率HRIRXRX
| Q4 25 | -331.7% | -304.2% | ||
| Q3 25 | -74.1% | -3135.3% | ||
| Q2 25 | -171.4% | -894.2% | ||
| Q1 25 | -332.8% | -1373.3% | ||
| Q4 24 | -250.3% | -3935.5% | ||
| Q3 24 | — | -367.5% | ||
| Q2 24 | — | -676.6% | ||
| Q1 24 | — | -662.4% |
每股收益（稀释后）HRIRXRX
| Q4 25 | $-0.36 | $-0.17 | ||
| Q3 25 | $-0.03 | $-0.36 | ||
| Q2 25 | $-0.08 | $-0.41 | ||
| Q1 25 | $-0.15 | $-0.50 | ||
| Q4 24 | $-0.15 | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $550.7M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $437.8M | $1.1B |
| 总资产 | $1.1B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资HRIRXRX
| Q4 25 | $550.7M | $743.3M | ||
| Q3 25 | $432.8M | $659.8M | ||
| Q2 25 | $67.6M | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | $30.0M | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务HRIRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $300.0K | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益HRIRXRX
| Q4 25 | $437.8M | $1.1B | ||
| Q3 25 | $486.1M | $1.0B | ||
| Q2 25 | $90.8M | $919.1M | ||
| Q1 25 | $26.1M | $933.9M | ||
| Q4 24 | $16.6M | $1.0B | ||
| Q3 24 | — | $524.6M | ||
| Q2 24 | — | $584.4M | ||
| Q1 24 | — | $401.2M |
总资产HRIRXRX
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $550.2M | $1.4B | ||
| Q2 25 | $152.0M | $1.3B | ||
| Q1 25 | $104.6M | $1.3B | ||
| Q4 24 | $109.6M | $1.4B | ||
| Q3 24 | — | $726.5M | ||
| Q2 24 | — | $775.9M | ||
| Q1 24 | — | $557.8M |
负债/权益比HRIRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | 0.02× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-12.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-47.3M |
| 自由现金流率自由现金流/营收 | -47.6% | -133.1% |
| 资本支出强度资本支出/营收 | 5.3% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-40.8M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流HRIRXRX
| Q4 25 | $-12.7M | $-46.1M | ||
| Q3 25 | $-11.0M | $-117.4M | ||
| Q2 25 | $-8.4M | $-76.4M | ||
| Q1 25 | $-6.7M | $-132.0M | ||
| Q4 24 | $-8.1M | $-115.4M | ||
| Q3 24 | — | $-59.2M | ||
| Q2 24 | — | $-82.2M | ||
| Q1 24 | — | $-102.3M |
自由现金流HRIRXRX
| Q4 25 | $-14.3M | $-47.3M | ||
| Q3 25 | $-11.1M | $-117.6M | ||
| Q2 25 | $-8.5M | $-79.6M | ||
| Q1 25 | $-6.8M | $-133.8M | ||
| Q4 24 | $-8.1M | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率HRIRXRX
| Q4 25 | -47.6% | -133.1% | ||
| Q3 25 | -110.2% | -2272.5% | ||
| Q2 25 | -135.5% | -413.9% | ||
| Q1 25 | -160.8% | -907.4% | ||
| Q4 24 | -197.1% | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度HRIRXRX
| Q4 25 | 5.3% | 3.5% | ||
| Q3 25 | 1.7% | 4.7% | ||
| Q2 25 | 1.5% | 16.4% | ||
| Q1 25 | 4.0% | 12.4% | ||
| Q4 24 | 0.7% | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRI
| Sales Of New Equipment | $9.0M | 30% |
| Sales Of Parts And Supplies | $8.0M | 27% |
| Other | $7.1M | 24% |
| Serviceand Other Revenue | $6.0M | 20% |
RXRX
暂无分部数据
